Clinical Trial Update: A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC [Phase 2]

View source ↗

Summary

This is a completed Phase 2 trial comparing Huachansu plus thoracic radiotherapy versus thoracic radiotherapy alone for Esophageal Squamous Cell Carcinoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Huachansu

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED